MIRM ranks #1898 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.
MIRM is a top-conviction position for Frazier Life Sciences Management, L.P. — at 19.6% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.
Fidelity has added to its MIRM position for two straight quarters, increasing it by $378.6M to reach $429.7M today.
David Shaw has trimmed its MIRM position for two straight quarters, cutting it by $71.6M while still holding $3.3M.
MIRM is up 0.3% today, and institutions have been net buyers of $1.3B this quarter — today's price move and the underlying institutional flow are pointing the same direction.